Remove tag healthcare-communications-association
article thumbnail

Grand Rounds July 7, 2023: Implementing Virtual Strategies Across an Integrated Healthcare System: The IMPLEMENT-HF Study (Ankeet S. Bhatt, MD, MBA, ScM)

Rethinking Clinical Trials

The daily workflow consisted of a daily electronic health record (EHR) query that identified patients who had heart failure with reduced ejection fraction, who were admitted for any cause within sites in the healthcare system. The recommendations were communicated in the EHR as a note and the primary team received a page notification.

article thumbnail

AI-Powered Precision Engagement in Commercial and Medical Functions

Intouch Solutions

Pre-Clinical : Deeper comprehension of the impacts and outcomes associated with a particular drug. Commercial : Improved experience and communication between patients and doctors. Clinical : Optimized efficiency, inventory management, and service quality of clinical trials. It uses customer insights to deliver personalized experiences.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Preview of Pharma Commercials at Super Bowl 2024: From Touching Down with TUMS to Tackling Menopause

XTalks

Along with the hefty price tag for screen time that may not be perceived to be a worthwhile investment, and despite favoring advertising at other major events like the Grammys, pharma tends to stay somewhat clear of all the Super Bowl hoopla.

article thumbnail

NICE ‘no’ to Roche’s risdiplam for SMA not unexpected, says patient group

pharmaphorum

NICE has rejected routine NHS funding for Roche’s Evrysdi (risdiplam) for spinal muscular atrophy drug in draft guidance, a decision which doesn’t come as a surprise to patient association SMA UK. Comments can be submitted until 23 June. — Spinal Muscular Atrophy UK (@SMA_UK_) June 2, 2021.

article thumbnail

Biogen’s Aducanumab Becomes First Drug Approved for Alzheimer’s in Nearly 20 Years Despite Controversy

XTalks

The historic and highly anticipated approval created a flurry of excitement in the Alzheimer’s disease space for patients, healthcare practitioners, advocacy groups and Biogen shareholders alike, as shares of the company jumped more than 50 percent after the announcement. Aducanumab Controversy and Price Tag.

Drugs 98
article thumbnail

Pharma By The Numbers: A Retrospective Look at the Industry and 20 Years of Xtalks History

XTalks

No matter how you’re looking to communicate your expertise in the life sciences, your audience is already here, so contact us to become an Xtalks partner. And make sure you’re registered for our free online community for instant access to thousands of on-demand webinars.

article thumbnail

Risk sharing agreements soar as market access risk increases

Pharmaceutical Technology

These agreements have been particularly propelled by the recent rise in inflationary pressures and pharmaceutical market instability, pushing healthcare systems to find new ways to reduce risks associated with new drugs. In some cases, she said, “[drug] innovation would have been otherwise hindered by their price tag alone”.

Marketing 257